Table 3.

Clinician Perspectives Regarding the Detection and Management of Hepatitis C

Survey Question% (n)
Compared with the common problems you face in practice, how important would you consider hepatitis C to be? (percent responding more important/important; N = 491)67.8 (333)
Compared with the common medical problems you screen for in practice, how important would you consider screening for HCV to be? (percent responding more important/important; N = 490)58.8 (288)
The extent to which you agree or disagree about whether primary care providers should be doing the following with respect to hepatitis C (percent responding strongly agree/agree; N = 494*)
    Screening87.5 (428)
    Diagnosis93.0 (456)
    Treatment with antiviral therapy29.6 (144)
    Monitoring and follow-up66.9 (327)
    Referral for consultation and comanagement of hepatitis C94.9 (463)
    Referral for all hepatitis C management50.6 (247)
How do you assess patients for these concerns (N = 490–494):
    Intravenous drug use
        Routinely ask new patients53.8 (266)
        Ask patients who give a history of other illicit drug use54.0 (267)
    Blood transfusion or solid organ transplant before July 1992
        Routinely ask new patients28.4 (139)
        Ask patients who have abnormal liver function tests42.7 (209)
Under what circumstances do you order serum ALT levels? (N = 487)
    Routine screen for new patients25.3 (123)
    Patients with other risk factors for hepatitis C60.6 (295)
    Patients with a history of hepatitis C56.3 (274)
How often do you order a hepatitis C antibody test? (percent responding always/frequently; N = 494*)
    Patient history of intravenous drug use75.9 (375)
    Patient history of blood transfusion/organ transplant before 199252.8 (261)
    Patient with an abnormal serum ALT79.6 (393)
What percent of patients in your practice with hepatitis C have you referred for treatment? (N = 394)
    <2523.6 (93)
    25–7530.2 (119)
    >7546.2 (182)
Do you routinely offer to patients with hepatitis C (N = 397)
    Counseling about alcohol avoidance93.7 (371)
    Counseling about acetaminophen avoidance78.6 (312)
    Hepatitis A vaccination/testing84.4 (335)
    Hepatitis B vaccination/testing89.7 (356)
    HIV testing82.4 (327)
  • * Minor differences in item responses (range, 487–490).

  • Clinicians with hepatitis C patients in their practices.

  • ALT, alanine aminotransferase; HIV, human immunodeficiency virus.